Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: Identification of L611S alone and in cis with V617F in polycythemia vera

Roberto H. Nussenzveig, Tatiana Burjanivova, Mohamed Salama, Natalie W. Ogilvie, Juraj Marcinek, Lukas Plank, Archana M. Agarwal, Sherrie L. Perkins, Josef T. Prchal

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

JAK2 mutations provide an objective major criterion for diagnosis of myeloproliferative neoplasms in the 2008 World Health Organization classification, and are particularly useful for cases of polycythemia vera (PV). High resolution melting analysis (HRM) using DNA from fresh samples for mutation detection in JAK2 exons 12 and 14 has been reported. Here, we describe two new HRM techniques that use both fresh and formalin-fixed paraffin-embedded marrow samples, allowing for both prospective and retrospective analyses. We used these novel assays to screen DNA isolated from paraffin-embedded marrow biopsies from 104 patients with PV for mutations. HRM mutation-positive samples were subsequently sequenced. Ninety-seven samples (93.3%) were positive solely for the JAK2 p.V617F. One harbored a 33 bp duplication in exon 12 along with an exon 14 p.V617F mutation, another had an exon 12 p.H538-K539delinsL, and a third carried a previously unreported mutation in PV, p.L611S, alone, and in cis with p.V617F. This indicates that these assays can detect known and novel JAK2 mutations in exons 12 and 14 using either fresh or paraffin-embedded archival materials.

Original languageEnglish (US)
Pages (from-to)2479-2486
Number of pages8
JournalLeukemia and Lymphoma
Volume53
Issue number12
DOIs
StatePublished - Dec 1 2012
Externally publishedYes

Fingerprint

Polycythemia Vera
Paraffin
Freezing
Bone Marrow
Biopsy
Mutation
Exons
DNA
Formaldehyde

Keywords

  • FFPE
  • High resolution melt
  • JAK2 exon 12
  • JAK2 exon 14
  • Mutation detection
  • Myeloproliferative neoplasm
  • Polycythemia vera

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis : Identification of L611S alone and in cis with V617F in polycythemia vera. / Nussenzveig, Roberto H.; Burjanivova, Tatiana; Salama, Mohamed; Ogilvie, Natalie W.; Marcinek, Juraj; Plank, Lukas; Agarwal, Archana M.; Perkins, Sherrie L.; Prchal, Josef T.

In: Leukemia and Lymphoma, Vol. 53, No. 12, 01.12.2012, p. 2479-2486.

Research output: Contribution to journalArticle

Nussenzveig, Roberto H. ; Burjanivova, Tatiana ; Salama, Mohamed ; Ogilvie, Natalie W. ; Marcinek, Juraj ; Plank, Lukas ; Agarwal, Archana M. ; Perkins, Sherrie L. ; Prchal, Josef T. / Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis : Identification of L611S alone and in cis with V617F in polycythemia vera. In: Leukemia and Lymphoma. 2012 ; Vol. 53, No. 12. pp. 2479-2486.
@article{add3bd8fedc84cf5bbab3d99ea1731e3,
title = "Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: Identification of L611S alone and in cis with V617F in polycythemia vera",
abstract = "JAK2 mutations provide an objective major criterion for diagnosis of myeloproliferative neoplasms in the 2008 World Health Organization classification, and are particularly useful for cases of polycythemia vera (PV). High resolution melting analysis (HRM) using DNA from fresh samples for mutation detection in JAK2 exons 12 and 14 has been reported. Here, we describe two new HRM techniques that use both fresh and formalin-fixed paraffin-embedded marrow samples, allowing for both prospective and retrospective analyses. We used these novel assays to screen DNA isolated from paraffin-embedded marrow biopsies from 104 patients with PV for mutations. HRM mutation-positive samples were subsequently sequenced. Ninety-seven samples (93.3{\%}) were positive solely for the JAK2 p.V617F. One harbored a 33 bp duplication in exon 12 along with an exon 14 p.V617F mutation, another had an exon 12 p.H538-K539delinsL, and a third carried a previously unreported mutation in PV, p.L611S, alone, and in cis with p.V617F. This indicates that these assays can detect known and novel JAK2 mutations in exons 12 and 14 using either fresh or paraffin-embedded archival materials.",
keywords = "FFPE, High resolution melt, JAK2 exon 12, JAK2 exon 14, Mutation detection, Myeloproliferative neoplasm, Polycythemia vera",
author = "Nussenzveig, {Roberto H.} and Tatiana Burjanivova and Mohamed Salama and Ogilvie, {Natalie W.} and Juraj Marcinek and Lukas Plank and Agarwal, {Archana M.} and Perkins, {Sherrie L.} and Prchal, {Josef T.}",
year = "2012",
month = "12",
day = "1",
doi = "10.3109/10428194.2012.697562",
language = "English (US)",
volume = "53",
pages = "2479--2486",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis

T2 - Identification of L611S alone and in cis with V617F in polycythemia vera

AU - Nussenzveig, Roberto H.

AU - Burjanivova, Tatiana

AU - Salama, Mohamed

AU - Ogilvie, Natalie W.

AU - Marcinek, Juraj

AU - Plank, Lukas

AU - Agarwal, Archana M.

AU - Perkins, Sherrie L.

AU - Prchal, Josef T.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - JAK2 mutations provide an objective major criterion for diagnosis of myeloproliferative neoplasms in the 2008 World Health Organization classification, and are particularly useful for cases of polycythemia vera (PV). High resolution melting analysis (HRM) using DNA from fresh samples for mutation detection in JAK2 exons 12 and 14 has been reported. Here, we describe two new HRM techniques that use both fresh and formalin-fixed paraffin-embedded marrow samples, allowing for both prospective and retrospective analyses. We used these novel assays to screen DNA isolated from paraffin-embedded marrow biopsies from 104 patients with PV for mutations. HRM mutation-positive samples were subsequently sequenced. Ninety-seven samples (93.3%) were positive solely for the JAK2 p.V617F. One harbored a 33 bp duplication in exon 12 along with an exon 14 p.V617F mutation, another had an exon 12 p.H538-K539delinsL, and a third carried a previously unreported mutation in PV, p.L611S, alone, and in cis with p.V617F. This indicates that these assays can detect known and novel JAK2 mutations in exons 12 and 14 using either fresh or paraffin-embedded archival materials.

AB - JAK2 mutations provide an objective major criterion for diagnosis of myeloproliferative neoplasms in the 2008 World Health Organization classification, and are particularly useful for cases of polycythemia vera (PV). High resolution melting analysis (HRM) using DNA from fresh samples for mutation detection in JAK2 exons 12 and 14 has been reported. Here, we describe two new HRM techniques that use both fresh and formalin-fixed paraffin-embedded marrow samples, allowing for both prospective and retrospective analyses. We used these novel assays to screen DNA isolated from paraffin-embedded marrow biopsies from 104 patients with PV for mutations. HRM mutation-positive samples were subsequently sequenced. Ninety-seven samples (93.3%) were positive solely for the JAK2 p.V617F. One harbored a 33 bp duplication in exon 12 along with an exon 14 p.V617F mutation, another had an exon 12 p.H538-K539delinsL, and a third carried a previously unreported mutation in PV, p.L611S, alone, and in cis with p.V617F. This indicates that these assays can detect known and novel JAK2 mutations in exons 12 and 14 using either fresh or paraffin-embedded archival materials.

KW - FFPE

KW - High resolution melt

KW - JAK2 exon 12

KW - JAK2 exon 14

KW - Mutation detection

KW - Myeloproliferative neoplasm

KW - Polycythemia vera

UR - http://www.scopus.com/inward/record.url?scp=84868370152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868370152&partnerID=8YFLogxK

U2 - 10.3109/10428194.2012.697562

DO - 10.3109/10428194.2012.697562

M3 - Article

C2 - 22642932

AN - SCOPUS:84868370152

VL - 53

SP - 2479

EP - 2486

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 12

ER -